Our data support an interdependent relationship between elevated S100A8/A9, systemic inflammatory response and development of cardiac dysfunction in sepsis, and demonstrate that pharmacologic S100A8/A9 blockade reverses the detrimental phenotype [3]. This evidence concerns the gene IGKV1D-22 and Sepsis.